HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feltz, A Articles by Trautmann, A Search for Related Content PubMed PubMed Citation Articles by Feltz, A Articles by Trautmann, A

1. Atropine action on the end-plate currents (e.p.c.s) has been analysed at the macroscopic and elementary levels. 2. The shortening effect of atropine on the e.p.c. and m.e.p.c. level can be fully explained by a reduction of the life time of the elementary current: this effect is markedly increased at more hyperpolarized membrane potentials and at higher concentrations of atropine. 3. It is therefore suggested that atropine binds to the open acetylcholine-receptor complex, leading to a state with a null conductance. According to this model, the forward rate constant of atropine binding could be calculated and was of the order of 10(7) M-1 S-1 AT -90 MV and 20-22 degrees C. 4. Although the conductance at the peak of the e.p.c. is reduced by atropine and becomes voltage sensitive, the elementary conductance is affected neither by voltage nor by atropine. 5. The exclusive binding of atropine to the activated ACh-receptor complex, as proposed above, does not appear to explain this phenomenon. Another binding occurring before the channel is open with a dissociation constant of 60 micrometer could account for this effect.

This article has been cited by other articles:

				T. Q. Duong, D.-S. Kim, K. Ugurbil, and S.-G. Kim Localized cerebral blood flow response at submillimeter columnar resolution PNAS, August 23, 2001; (2001) 191101098. [Abstract] [Full Text] [PDF]

				R. Zwart and H. P. M. Vijverberg Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects Mol. Pharmacol., November 1, 1997; 52(5): 886 - 895. [Abstract] [Full Text]

				W. B. Church, A. S. Inglis, A. Tseng, R. Duell, P.-W. Lei, K. J. Bryant, and K. F. Scott A Novel Approach to the Design of Inhibitors of Human Secreted Phospholipase A2 Based on Native Peptide Inhibition J. Biol. Chem., August 24, 2001; 276(35): 33156 - 33164. [Abstract] [Full Text] [PDF]